PURA VIDA INVESTMENTS, LLC
Top Portfolio Positions
16 positions ·
$14,537,872 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| IMDX |
Insight Molecular Diagnostics Inc.
Healthcare
|
947,134 | $3,106,599 | 21.37% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
281,250 | $2,818,125 | 19.38% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
45,000 | $2,555,100 | 17.58% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
89,940 | $1,608,127 | 11.06% | |
| NSPR |
InspireMD, Inc.
Healthcare
|
450,517 | $734,342 | 5.05% | |
| NTRA |
Natera, Inc.
Healthcare
|
2,500 | $499,975 | 3.44% | |
| NVDA |
Nvidia Corp
Technology
|
2,500 | $436,000 | 3.00% | |
| JPM |
Jpmorgan Chase & Co
Financial Services
|
1,350 | $397,116 | 2.73% | |
| MSFT |
Microsoft Corp
Technology
|
990 | $366,468 | 2.52% | |
| MGX |
Metagenomi Therapeutics, Inc.
Healthcare
|
264,391 | $354,283 | 2.44% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CAI
Shares Held
Position Value (USD)
4 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,608,127 | 89,940 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,426,581 | 89,940 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,720,685 | 89,940 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,202,400 | 45,000 | Shares | Sole | 2025-08-13 | |
| No 13F history on record for this holder in this stock. | ||||||